Understand
the impact of incorrect nutrition on disease pathophysiology
Explain
the role of abnormal adiposity and euglycemic insulin resistance in the
onset and progressive risk of dysglycemia
Establish
the biological basis for targeted action
Key focus
Dysglycemia based chronic disease model as described by the AACr
Intermediating roles of metabolic drivers
Insulin resistance, and abnormal adiposity
and resultant beta cell dysfunction in
stage 1 progressing to stage 2
